Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma
Open Access
- 9 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 40 (42), 6130-6138
- https://doi.org/10.1038/s41388-021-02005-y
Abstract
Neoantigen peptides arising from genetic alterations may serve as targets for personalized cancer vaccines and as positive predictors of response to immune checkpoint therapy. Mutations in genes regulating RNA splicing are common in hematological malignancies leading to dysregulated splicing and intron retention (IR). In this study, we investigated IR as a potential source of tumor neoantigens in multiple myeloma (MM) patients and the relationship of IR-induced neoantigens (IR-neoAg) with clinical outcomes. MM-specific IR events were identified in RNA-sequencing data from the Multiple Myeloma Research Foundation CoMMpass study after removing IR events that also occurred in normal plasma cells. We quantified the IR-neoAg load by assessing IR-induced novel peptides that were predicted to bind to major histocompatibility complex (MHC) molecules. We found that high IR-neoAg load was associated with poor overall survival in both newly diagnosed and relapsed MM patients. Further analyses revealed that poor outcome in MM patients with high IR-neoAg load was associated with high expression levels of T-cell co-inhibitory molecules and elevated interferon signaling activity. We also found that MM cells exhibiting high IR levels had lower MHC-II protein abundance and treatment of MM cells with a spliceosome inhibitor resulted in increased MHC-I protein abundance. Our findings suggest that IR-neoAg may represent a novel biomarker of MM patient clinical outcome and further that targeting RNA splicing may serve as a potential therapeutic strategy to prevent MM immune escape and promote response to checkpoint blockade.Funding Information
- Indiana University (Indiana University Grand Challenge Precision Health Initiative)
This publication has 66 references indexed in Scilit:
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Coordinated regulation of neuronal mRNA steady-state levels through developmentally controlled intron retentionGenes & Development, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformationNature Structural & Molecular Biology, 2012
- Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translationProceedings of the National Academy of Sciences of the United States of America, 2011
- Expansion of the eukaryotic proteome by alternative splicingNature, 2010
- Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunityNature Reviews Immunology, 2004
- Cox Analysis of Survival Data with Non-Proportional Hazard FunctionsJournal of the Royal Statistical Society: Series D (The Statistician), 1992